Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Ngo · SciRah

Researcher profile · Semantic Scholar

K. Ngo

Share profile

K. Ngo — researcher profile on SciRah

h-index: 13
Works: 33
Citations: 766

Most-cited papers

Immunity to Commensal Papillomaviruses protects against Skin Cancer
J. Strickley, Jonathan L. Messerschmidt, Mary E. Awad, Tiancheng Li +11 more
2019Nature129 citations Open access
Semantic Scholar
Acute pharmacological degradation of Helios destabilizes regulatory T cells
Eric S. Wang, Alyssa L Verano, R. Nowak, J. Yuan +8 more
2021Nature Chemical Biology102 citations Open access
Semantic Scholar
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
A. Rosenberg, M. Tabacchi, K. Ngo, M. Wallendorf +3 more
2019JCI Insight90 citations Open access
Semantic Scholar
IL-33/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation
A. Ameri, Sara Moradi Tuchayi, Anniek Zaalberg, J. H. Park +7 more
2019Proceedings of the National Academy of Sciences of the United States of America82 citations Open access
Semantic Scholar
Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis.
S. Demehri, T. Cunningham, Sindhu Manivasagam, K. Ngo +5 more
2016Journal of Clinical Investigation71 citations Open access
Semantic Scholar
EGFR inhibition enhances the cellular uptake and antitumor-activity of the HER3 antibody drug conjugate HER3-DXd
Heidi M. Haikala, T. Lopez, Jens Köhler, P. Eser +20 more
2021Cancer Research68 citations Open access
Semantic Scholar
Chronic inflammation promotes skin carcinogenesis in cancer-prone discoid lupus erythematosus
Anniek Zaalberg, Sara Moradi Tuchayi, A. Ameri, K. Ngo +8 more
2018Journal of Investigative Dermatology49 citations Open access
Semantic Scholar
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
S. Baldacci, E. Brea, F. Facchinetti, Zhao-Rong Li +33 more
2025Cancer Discovery34 citations Open access
Semantic Scholar
Reduction in human epidermal Langerhans cells with age is associated with decline in CXCL14-mediated recruitment of CD14+ monocytes
T. Hasegawa, Zhaoyi Feng, Zhiyu Yan, K. Ngo +2 more
2019Journal of Investigative Dermatology29 citations Open access
Semantic Scholar
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease
G. Molina, Saami Khalifian, Jamie L. Mull, Lu Chen +6 more
2019JAMA dermatology25 citations Open access
Semantic Scholar
Targeting G1–S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors
Shilpa Singh, C. Gleason, Min Fang, Y. Laimon +55 more
2025Nature22 citations Open access
Semantic Scholar
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer
P. Eser, Raymond M. Paranal, Jieun Son, E. Ivanova +37 more
2021Science Translational Medicine17 citations Open access
Semantic Scholar
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
M. Campisi, Tatsuya Osaki, I. Dryg, C. Stornante +59 more
2026Cancer Cell14 citations Open access
Semantic Scholar
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Francesca Nardi, N. Perurena, Amy E. Schade, Ze-Cang Li +10 more
2023Journal of Clinical Investigation12 citations Open access
Semantic Scholar
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Atsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, N. Mahadevan +28 more
2026JCI Insight5 citations Open access
Semantic Scholar
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
E. Brea, S. Baldacci, N. Savage, F. Facchinetti +32 more
2025Cancer immunology research4 citations Open access
Semantic Scholar
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity
Shilpa Singh, C. Gleason, Min Fang, Y. Laimon +50 more
2024bioRxiv4 citations Open access
Semantic Scholar
Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
Marjan Azin, K. Ngo, Jennet Hojanazarova, S. Demehri
2023JID Innovations4 citations Open access
Semantic Scholar
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK
Andrew R. Conery, Daniel S. La, A. A. Alekseyenko, D. Marcoux +24 more
2026Nature3 citations
Semantic Scholar
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer
Ze-Hua Li, Cong Fu, Kartik Sehgal, A. Egloff +22 more
2026Nature Communications2 citations Open access
Semantic Scholar
Abstract 5787: TRI-611, a development stage molecular glue degrader of ALK, promotes the degradation of TKI-resistant ALK fusion proteins and leads to regression of ALK TKI-refractory tumors
Andrew R. Conery, Daniel S. La, A. A. Alekseyenko, D. Marcoux +21 more
2026Cancer Research1 citations
Semantic Scholar
Abstract 333: Activity of the erythropoietin-producing hepatocellular A2 receptor (EphA2) targeting Bicycle® Toxin Conjugate (BTC™) BCY6033 in EGFR inhibitor resistant non-small lung cancer (NSCLC) patient derived xenografts
K. Ngo, E. Ivanova, Tyler J. Teceno, Carly Campbell +6 more
2022Cancer Research1 citations
Semantic Scholar
84 The Role of the GNAS Oncogene in the Immune Microenvironment of Intraductal Papillary Mucinous Neoplasm
Y. Hernandez-Barco, Christina M. Ferrer, K. Ngo, Erik B. Schiferle +6 more
2019American Journal of Gastroenterology1 citations
Semantic Scholar
Abstract ND07: TRI-611, a potent, selective, CNS-penetrant ALK molecular glue degrader for the treatment of ALK-fusion protein positive non-small cell lung cancer
V. Palombella, Daniel S. La, Andrew R. Conery, A. A. Alekseyenko +18 more
2026Cancer Research0 citations
Semantic Scholar
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
C. Gentile, William W. Feng, Sean M. Lenahan, A. Ying +22 more
2026bioRxiv0 citations Open access
Semantic Scholar
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity
Shilpa Singh, C. Gleason, Min Fang, Y. Laimon +50 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
1022 Evaluating the mechanism of enhanced responses to the IV STING agonist dazostinag (TAK-676) plus pembrolizumab in neuroendocrine tumors
Emily Rosentrater, P. Gokhale, C. Paweletz, P. Lizotte +13 more
2024Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Abstract 3065: Establishment and characterization of a platform of endometrial cancer organoids
Aisha Saldanha, H. Vo, Kevin A. Vasquez, K. Ngo +12 more
2022Cancer Research0 citations
Semantic Scholar
581 Topical calcipotriol plus imiquimod immunotherapy for non-keratinocyte skin cancers
M. Azin, K. Ngo, S. Demehri
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
509 Decline in Langerhans cell precursor recruitment into the human skin explains the reduction in epidermal Langerhans cells with age
T. Hasegawa, Z. Feng, Z. Yan, K. Ngo +2 more
2019Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
Abstract 4948: T helper 2 cells block breast cancer promotion
M. Boieri, Anna Malishkevich, Lauren E. Steidl, K. Ngo +6 more
2019Immunology0 citations
Semantic Scholar
132 IL-33 - T regulatory cell axis triggers development of a cancer-promoting immune environment in chronic inflammation
A. Ameri, S. Tuchayi, Anniek Zaalberg, K. Ngo +5 more
20180 citations Open access
Semantic Scholar
294 IL-33 mediates the development of the tumor-promoting immune environment in chronic inflammation
S. Tuchayi, T. Cunningham, K. Ngo, T. Raissi +5 more
20170 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Demehri×12
Invite
S. Demehri — researcher profile on SciRah
C. Paweletz×11
Invite
C. Paweletz — researcher profile on SciRah
Prafulla C. Gokhale×9
Invite
Prafulla C. Gokhale — researcher profile on SciRah
B. Tuladhar×7
Invite
B. Tuladhar — researcher profile on SciRah

×7

Invite

P. Jänne — researcher profile on SciRah

Invite

P. Gokhale — researcher profile on SciRah

Invite

E. Ivanova — researcher profile on SciRah

N. Mahadevan×5

Invite

N. Mahadevan — researcher profile on SciRah

Invite

D. Barbie — researcher profile on SciRah

Invite

M. Oser — researcher profile on SciRah

T. Cunningham×4

Invite

T. Cunningham — researcher profile on SciRah

Invite

M. Locquet — researcher profile on SciRah